Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing December 14, 2020
Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology December 1, 2020
Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine November 23, 2020
Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference September 8, 2020
Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders July 20, 2020
Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office July 10, 2020
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds July 6, 2020